Cargando…
Treatments for patients with advanced neuroendocrine tumors: a network meta-analysis
BACKGROUND: It remains unknown which is the most effective regimen among the available therapies for advanced well-differentiated neuroendocrine tumors (NETs). We performed a network meta-analysis to address this important issue. METHODS: PubMed, Embase, Web of Science, Cochrane Library, and major i...
Autores principales: | Liu, Tingting, Liao, Jiehao, Dang, Jun, Li, Guang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6542116/ https://www.ncbi.nlm.nih.gov/pubmed/31191714 http://dx.doi.org/10.1177/1758835919853673 |
Ejemplares similares
-
Comparative risk of serious and fatal treatment-related adverse events caused by 19 immune checkpoint inhibitors used in cancer treatment: a network meta-analysis
por: Liu, Tingting, et al.
Publicado: (2020) -
Network meta-analysis of the efficacy and adverse effects of several treatments for advanced/metastatic prostate cancer
por: Wu, Jing, et al.
Publicado: (2017) -
First-line treatments for patients with advanced ALK gene rearrangements in NSCLC: a systematic review and network meta-analysis
por: Tao, Jiahao, et al.
Publicado: (2022) -
Gastric neuroendocrine neoplasms type 1: A systematic review and meta-analysis
por: Tsolakis, Apostolos V, et al.
Publicado: (2019) -
Network meta-analysis of the efficacy of first-line chemotherapy regimens in patients with advanced colorectal cancer
por: Wu, Dong-Mei, et al.
Publicado: (2017)